Table 37
|
Mastectomy versus lumpectomy (breast conserving surgery) plus radiation and overall survival in early breast cancer
|
Table 38
|
Radiation therapy following mastectomy and overall survival in stage II & III breast cancer
|
Table 39
|
Adjuvant chemotherapy and overall survival
|
Table 40
|
Different adjuvant chemotherapy combinations and overall survival in early breast cancer
|
Table 41
|
Tamoxifen and overall survival in estrogen receptor-positive breast cancer
|
Table 42
|
Trastuzumab (Herceptin) and overall survival in early breast cancer
|
Table 43
|
Aromatase inhibitors and disease-free survival in early breast cancer
|
Table 44
|
Lumpectomy plus radiation therapy in the treatment of ductal carcinoma in situ (DCIS)
|
Table 45
|
Tamoxifen in the treatment of ductal carcinoma in situ (DCIS)
|
Table 46
|
Neoadjuvant (preoperative) chemotherapy for women with stage II or stage III breast cancer
|
Table 47
|
Neoadjuvant (preoperative) hormone therapy for women with estrogen receptor-positive breast cancer
|
Table 48
|
High-dose chemotherapy with stem cell transplant for women with metastatic breast cancer and for women with non-metastatic breast cancer at high risk for recurrence
|
Table 49
|
Combined modality treatment and overall survival in inflammatory breast cancer
|
Table 50
|
Trastuzumab (Herceptin) for treatment of metastatic breast cancer
|
Table 51
|
Lapatinib (Tykerb) for treatment of metastatic breast cancer
|